ACHILLION PHARMACEUTICALS INC Research and Development Expense
ACHILLION PHARMACEUTICALS INC reported Research and Development Expense of $14.99 million for the 3-month period ending 2019-09-30, per its 10-Q filed 2019-11-07.
Discontinued › Expense Statement › Operating Expenses
us-gaap:ResearchAndDevelopmentExpense · last filed 2019-11-07
- ACHILLION PHARMACEUTICALS INC research and development expense for the quarter ending 2019-09-30 was $14.99M, a 16.75% increase year-over-year.
- ACHILLION PHARMACEUTICALS INC research and development expense for the quarter ending 2019-06-30 was $15.93M, a 44.53% increase year-over-year.
- ACHILLION PHARMACEUTICALS INC research and development expense for the quarter ending 2019-03-31 was $14.82M, a 5.47% increase year-over-year.
- ACHILLION PHARMACEUTICALS INC research and development expense for the quarter ending 2018-12-31 was $12.20M, a 14.30% decline year-over-year.
- ACHILLION PHARMACEUTICALS INC research and development expense for fiscal 2018 was $50.12M, a 21.21% decline from fiscal 2017.
- ACHILLION PHARMACEUTICALS INC research and development expense for fiscal 2017 was $63.61M, a 11.90% increase from fiscal 2016.
- ACHILLION PHARMACEUTICALS INC research and development expense for fiscal 2016 was $56.84M, a 0.51% increase from fiscal 2015.
- ACHILLION PHARMACEUTICALS INC research and development expense for fiscal 2015 was $56.55M, a 5.68% increase from fiscal 2014.
| Period end | Research and Development Expense 3 month | Research and Development Expense 3 month as first filed | Research and Development Expense 6 month | Research and Development Expense 6 month as first filed | Research and Development Expense 9 month | Research and Development Expense 9 month as first filed | Research and Development Expense 12 month | Research and Development Expense 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2019-09-30 | $14.99M 10-Q · filed 2019-11-07 | $30.93M derived: sum of 2 quarters · filed 2019-11-07 | $45.74M 10-Q · filed 2019-11-07 | $57.95M derived: sum of 4 quarters · filed 2019-11-07 | ||||
| 2019-06-30 | $15.93M 10-Q · filed 2019-08-08 | $30.75M 10-Q · filed 2019-08-08 | $42.95M derived: sum of 3 quarters · filed 2019-08-08 | $55.79M derived: sum of 4 quarters · filed 2019-11-07 | ||||
| 2019-03-31 | $14.82M 10-Q · filed 2019-05-09 | $27.02M derived: sum of 2 quarters · filed 2019-05-09 | $39.86M derived: sum of 3 quarters · filed 2019-11-07 | $50.88M derived: sum of 4 quarters · filed 2019-11-07 | ||||
| 2018-12-31 | $12.20M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-07 | $25.05M derived: sum of 2 quarters · filed 2019-11-07 | $36.07M derived: sum of 3 quarters · filed 2019-11-07 | $50.12M 10-K · filed 2019-03-07 | ||||
| 2018-09-30 | $12.84M 10-Q · filed 2019-11-07 | $13.14M 10-Q · filed 2018-11-07 | $23.86M derived: sum of 2 quarters · filed 2019-11-07 | $37.91M 10-Q · filed 2019-11-07 | $39.28M 10-Q · filed 2018-11-07 | $52.15M derived: sum of 4 quarters · filed 2019-11-07 | ||
| 2018-06-30 | $11.02M 10-Q · filed 2019-08-08 | $11.39M 10-Q · filed 2018-08-08 | $25.07M 10-Q · filed 2019-08-08 | $26.14M 10-Q · filed 2018-08-08 | $39.31M derived: sum of 3 quarters · filed 2019-08-08 | $54.93M derived: sum of 4 quarters · filed 2019-08-08 | ||
| 2018-03-31 | $14.05M 10-Q · filed 2019-05-09 | $14.75M 10-Q · filed 2018-05-02 | $28.29M derived: sum of 2 quarters · filed 2019-05-09 | $43.91M derived: sum of 3 quarters · filed 2019-05-09 | $62.16M derived: sum of 4 quarters · filed 2019-05-09 | |||
| 2017-12-31 | $14.24M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-07 | $29.86M derived: sum of 2 quarters · filed 2019-03-07 | $48.11M derived: sum of 3 quarters · filed 2019-03-07 | $63.61M 10-K · filed 2019-03-07 | $65.05M 10-K · filed 2018-02-22 | |||
| 2017-09-30 | $15.62M 10-Q · filed 2018-11-07 | $33.87M derived: sum of 2 quarters · filed 2018-11-07 | $49.37M 10-Q · filed 2018-11-07 | $62.08M derived: sum of 4 quarters · filed 2019-03-07 | ||||
| 2017-06-30 | $18.25M 10-Q · filed 2018-08-08 | $33.75M 10-Q · filed 2018-08-08 | $46.46M derived: sum of 3 quarters · filed 2019-03-07 | $63.16M derived: sum of 4 quarters · filed 2019-03-07 | ||||
| 2017-03-31 | $15.49M 10-Q · filed 2018-05-02 | $28.20M derived: sum of 2 quarters · filed 2019-03-07 | $44.91M derived: sum of 3 quarters · filed 2019-03-07 | $59.06M derived: sum of 4 quarters · filed 2019-03-07 | ||||
| 2016-12-31 | $12.71M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-07 | $29.41M derived: sum of 2 quarters · filed 2019-03-07 | $43.56M derived: sum of 3 quarters · filed 2019-03-07 | $56.84M 10-K · filed 2019-03-07 | $59.16M 10-K · filed 2017-02-23 | |||
| 2016-09-30 | $16.70M 10-Q · filed 2017-11-01 | $30.86M derived: sum of 2 quarters · filed 2017-11-01 | $44.13M 10-Q · filed 2017-11-01 | $53.77M derived: sum of 4 quarters · filed 2018-02-22 | ||||
| 2016-06-30 | $14.15M 10-Q · filed 2017-08-08 | $27.43M 10-Q · filed 2017-08-08 | $37.07M derived: sum of 3 quarters · filed 2018-02-22 | $49.06M derived: sum of 4 quarters · filed 2018-02-22 | ||||
| 2016-03-31 | $13.28M 10-Q · filed 2017-05-04 | $22.92M derived: sum of 2 quarters · filed 2018-02-22 | $34.90M derived: sum of 3 quarters · filed 2018-02-22 | $54.67M derived: sum of 4 quarters · filed 2018-02-22 | ||||
| 2015-12-31 | $9.64M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-22 | $21.62M derived: sum of 2 quarters · filed 2018-02-22 | $41.40M derived: sum of 3 quarters · filed 2018-02-22 | $56.55M 10-K · filed 2018-02-22 | ||||
| 2015-09-30 | $11.98M 10-Q · filed 2016-11-03 | $31.75M derived: sum of 2 quarters · filed 2016-11-03 | $46.91M 10-Q · filed 2016-11-03 | $63.34M derived: sum of 4 quarters · filed 2017-02-23 | ||||
| 2015-06-30 | $19.77M 10-Q · filed 2016-08-04 | $34.93M 10-Q · filed 2016-08-04 | $51.35M derived: sum of 3 quarters · filed 2017-02-23 | $63.42M derived: sum of 4 quarters · filed 2017-02-23 | ||||
| 2015-03-31 | $15.16M 10-Q · filed 2016-05-03 | $31.58M derived: sum of 2 quarters · filed 2017-02-23 | $43.65M derived: sum of 3 quarters · filed 2017-02-23 | $55.83M derived: sum of 4 quarters · filed 2017-02-23 | ||||
| 2014-12-31 | $16.43M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-23 | $28.50M derived: sum of 2 quarters · filed 2017-02-23 | $40.67M derived: sum of 3 quarters · filed 2017-02-23 | $53.52M 10-K · filed 2017-02-23 | ||||
| 2014-09-30 | $12.07M 10-Q · filed 2015-11-05 | $24.25M derived: sum of 2 quarters · filed 2015-11-05 | $37.09M 10-Q · filed 2015-11-05 | $47.20M derived: sum of 4 quarters · filed 2016-02-25 | ||||
| 2014-06-30 | $12.18M 10-Q · filed 2015-08-10 | $25.02M 10-Q · filed 2015-08-10 | $35.13M derived: sum of 3 quarters · filed 2016-02-25 | $46.47M derived: sum of 4 quarters · filed 2016-02-25 | ||||
| 2014-03-31 | $12.84M 10-Q · filed 2015-05-07 | $22.95M derived: sum of 2 quarters · filed 2016-02-25 | $34.29M derived: sum of 3 quarters · filed 2016-02-25 | $50.86M derived: sum of 4 quarters · filed 2016-02-25 | ||||
| 2013-12-31 | $10.11M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-25 | $21.45M derived: sum of 2 quarters · filed 2016-02-25 | $38.02M derived: sum of 3 quarters · filed 2016-02-25 | $46.74M 10-K · filed 2016-02-25 | ||||
| 2013-09-30 | $11.34M 10-Q · filed 2014-11-04 | $27.91M derived: sum of 2 quarters · filed 2014-11-04 | $36.63M 10-Q · filed 2014-11-04 | $45.07M derived: sum of 4 quarters · filed 2015-03-05 | ||||
| 2013-06-30 | $16.57M 10-Q · filed 2014-08-07 | $25.29M 10-Q · filed 2014-08-07 | $33.72M derived: sum of 3 quarters · filed 2015-03-05 | $46.37M derived: sum of 4 quarters · filed 2015-03-05 | ||||
| 2013-03-31 | $8.72M 10-Q · filed 2014-05-07 | $17.16M derived: sum of 2 quarters · filed 2015-03-05 | $29.80M derived: sum of 3 quarters · filed 2015-03-05 | $38.78M derived: sum of 4 quarters · filed 2015-03-05 | ||||
| 2012-12-31 | $8.44M derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-05 | $21.08M derived: sum of 2 quarters · filed 2015-03-05 | $30.06M derived: sum of 3 quarters · filed 2015-03-05 | $39.00M 10-K · filed 2015-03-05 | ||||
| 2012-09-30 | $12.64M 10-Q · filed 2013-11-12 | $21.62M derived: sum of 2 quarters · filed 2013-11-12 | $30.56M 10-Q · filed 2013-11-12 | $40.50M derived: sum of 4 quarters · filed 2014-03-07 | ||||
| 2012-06-30 | $8.98M 10-Q · filed 2013-08-07 | $17.92M 10-Q · filed 2013-08-07 | $27.86M derived: sum of 3 quarters · filed 2014-03-07 | $36.47M derived: sum of 4 quarters · filed 2014-03-07 | ||||
| 2012-03-31 | $8.94M 10-Q · filed 2013-05-07 | $18.88M derived: sum of 2 quarters · filed 2014-03-07 | $27.49M derived: sum of 3 quarters · filed 2014-03-07 | $36.39M derived: sum of 4 quarters · filed 2014-03-07 | ||||
| 2011-12-31 | $9.94M derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-07 | $18.55M derived: sum of 2 quarters · filed 2014-03-07 | $27.45M derived: sum of 3 quarters · filed 2014-03-07 | $35.44M 10-K · filed 2014-03-07 | ||||
| 2011-09-30 | $8.62M 10-Q · filed 2012-11-08 | $17.51M derived: sum of 2 quarters · filed 2012-11-08 | $25.50M 10-Q · filed 2012-11-08 | $31.60M derived: sum of 4 quarters · filed 2013-02-20 | ||||
| 2011-06-30 | $8.90M 10-Q · filed 2012-08-08 | $16.89M 10-Q · filed 2012-08-08 | $22.99M derived: sum of 3 quarters · filed 2013-02-20 | $28.64M derived: sum of 4 quarters · filed 2013-02-20 | ||||
| 2011-03-31 | $7.99M 10-Q · filed 2012-05-09 | $14.09M derived: sum of 2 quarters · filed 2013-02-20 | $19.75M derived: sum of 3 quarters · filed 2013-02-20 | $24.56M derived: sum of 4 quarters · filed 2013-02-20 | ||||
| 2010-12-31 | $6.10M derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-20 | $11.76M derived: sum of 2 quarters · filed 2013-02-20 | $16.57M derived: sum of 3 quarters · filed 2013-02-20 | $20.53M 10-K · filed 2013-02-20 | ||||
| 2010-09-30 | $5.66M 10-Q · filed 2011-11-08 | $10.47M derived: sum of 2 quarters · filed 2011-11-08 | $14.43M 10-Q · filed 2011-11-08 | |||||
| 2010-06-30 | $4.81M 10-Q · filed 2011-08-08 | $8.77M 10-Q · filed 2011-08-08 | ||||||
| 2009-12-31 | $18.42M 10-K · filed 2012-03-08 |